Ricerca

Pubblicazioni IRIS

• Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial
  Anno: 2021
• Lenvatinib plus pembrolizumab or everolimus for advanced renal cell carcinoma
  Anno: 2021
• The prognostic role of baseline metabolic tumor burden and systemic inflammation biomarkers in metastatic castration-resistant prostate cancer patients treated with Radium-223: A proof of concept study
  Anno: 2020
• Call for ensuring cancer care continuity during COVID-19 pandemic
  Anno: 2020
• Managing the unexpected: Carcinosarcoma of the kidney parenchyma A case with the longest follow-up
  Anno: 2020

Altre informazioni

Pubblicazioni

Elenco pubblicazioni